Skip to main content
Equibles
MPT logo

MPT · Medical Properties Trust Inc

Track MPT — free

Use MPT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.01 -0.03 (-0.74%) At close · Sep 4
S&P 600 member Russell 1000 member Rebalance outlook locked
Market Cap
$2.42B
Shares
598.10M

MPT metrics

70 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.01
Market cap
$2.42B

Price action

19 metrics
Price change (1W)
-2.0%
Price change (30D)
-12.8%
Price change (3M)
-19.5%
Price change (6M)
-26.7%
Price change (YTD)
-19.8%
Price change (1Y)
-9.9%
Trailing year
Price change (5Y)
-81.5%
52-week high
$6.02
52-week low
$3.97
Change from 52-week high
-33.4%
Change from 52-week low
+1.0%
Annualized volatility
37.7%
Beta
0.4
RSI (14D)
38.0
Price vs SMA 50
-9.5%
Price vs SMA 200
-19.1%
Avg volume (3M)
6.91M
Relative volume
1.1
Average dollar volume
$30.65M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
598.10M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
11.7×
reciprocal yield 8.6%
EV / EBITDA
11.6×
reciprocal yield 8.6%
EV / EBIT
14.7×
reciprocal yield 6.8%
P / sales
2.4×
reciprocal yield 41.4%
P / book
0.5
reciprocal yield 188.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
11.2
reciprocal yield 8.9%
Earnings yield
-5.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
30.9×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
13.1×
reciprocal yield 7.6%
EV / revenue historical average (5Y)
13.2×
reciprocal yield 7.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
8.7%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.35
Dividend growth YoY
+9.4%
Dividend growth streak
—
Last ex-dividend
2026-06-18

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
90.7%
Operating margin
—
Trailing 12 months
Net margin
-12.6%
Gross profit (TTM)
—
Operating profit (TTM)
$485.58M
Net income (TTM)
−$126.24M
Trailing 12 months
Diluted EPS (TTM)
$-0.21
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.38
EBITDA per diluted share (TTM)
$1.76
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.16

Growth

11 metrics
Revenue growth YoY
+12.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.00B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-14.3%
Revenue CAGR (5Y)
-4.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-2.8%
Return on assets
-0.9%
Debt / equity
2.1
Current ratio
—
EBITDA (TTM)
$617.56M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
7.7
Return on invested capital
—
Trailing 12 months
Net cash
−$9.24B
Latest balance sheet
Cash & equivalents
$425.00M
Total assets
$14.76B
Total debt
$9.66B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$216.12M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
496
13F filer change QoQ
-9
Institutional ownership
64.2%

Short interest

3 metrics
Short interest
24.2%
Latest settlement · 15.6 days to cover
Days to cover
15.6d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
$9,545
Insider-sentiment score
73 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1287865 CUSIP 58463J304 13F (30d) 326 filings 306 filers Visit website Investor relations